We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The V86M mutation in HIV-1 capsid confers resistance to TRIM5a by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
- Authors
Veillette, Maxime; Bichel, Katsiaryna; Pawlica, Paulina; Freund, Stefan M. V.; Plourde, Mélodie B.; Pham, Quang Toan; Reyes-Moreno, Carlos; James, Leo C.; Berthoux, Lionel
- Abstract
Background: HIV-1 is inhibited early after entry into cells expressing some simian orthologues of the tripartite motif protein family member TRIM5a. Mutants of the human orthologue (TRIM5ahu) can also provide protection against HIV-1. The host protein cyclophilin A (CypA) binds incoming HIV-1 capsid (CA) proteins and enhances early stages of HIV-1 replication by unknown mechanisms. On the other hand, the CA-CypA interaction is known to increase HIV-1 susceptibility to restriction by TRIM5a. Previously, the mutation V86M in the CypA-binding loop of HIV-1 CA was found to be selected upon serial passaging of HIV-1 in cells expressing Rhesus macaque TRIM5a (TRIM5arh). The objectives of this study were (i) to analyze whether V86M CA allows HIV-1 to escape mutants of TRIM5ahu, and (ii) to characterize the role of CypA in the resistance to TRIM5a conferred by V86M. Results: We find that in single-cycle HIV-1 vector transduction experiments, V86M confers partial resistance against R332G-R335G TRIM5ahu and other TRIM5ahu variable 1 region mutants previously isolated in mutagenic screens. However, V86M HIV-1 does not seem to be resistant to R332G-R335G TRIM5ahu in a spreading infection context. Strikingly, restriction of V86M HIV-1 vectors by TRIM5ahu mutants is mostly insensitive to the presence of CypA in infected cells. NMR experiments reveal that V86M alters CypA interactions with, and isomerisation of CA. On the other hand, V86M does not affect the CypA-mediated enhancement of HIV-1 replication in permissive human cells. Finally, qPCR experiments show that V86M increases HIV-1 transport to the nucleus of cells expressing restrictive TRIM5a. Conclusions: Our study shows that V86M de-couples the two functions associated with CA-CypA binding, i.e. the enhancement of restriction by TRIM5a and the enhancement of HIV-1 replication in permissive human cells. V86M enhances the early stages of HIV-1 replication in restrictive cells by improving nuclear import. In summary, our data suggest that HIV-1 escapes restriction by TRIM5a through the selective disruption of CypA-dependent, TRIM5a- mediated inhibition of nuclear import. However, V86M does not seem to relieve restriction of a spreading HIV-1 infection by TRIM5ahu mutants, underscoring context-specific restriction mechanisms.
- Subjects
HIV infections; THERAPEUTICS; GENETIC mutation; CAPSIDS; CYCLOPHILINS; CELLULAR signal transduction; PROTEIN binding; GENE expression; VIRAL replication
- Publication
Retrovirology, 2013, Vol 10, Issue 1, p1
- ISSN
1742-4690
- Publication type
Article
- DOI
10.1186/1742-4690-10-25